UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes

Human gene therapy, 2013-06, Vol.24 (6), p.630-640

2013

Volltextzugriff (PDF)

Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation

Molecular therapy. Methods & clinical development, 2023-09, Vol.30, p.303-314

2023

Volltextzugriff (PDF)

Pompe disease gene therapy: Gene Therapy

Human molecular genetics, 2011-04, Vol.20 (1), p.R61-R68

2011

Volltextzugriff (PDF)

A simplified purification protocol for recombinant adeno-associated virus vectors

Molecular therapy. Methods & clinical development, 2014-01, Vol.1 (C), p.14034-14034, Article 14034

2014

Volltextzugriff (PDF)

Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning

Human gene therapy. Clinical development, 2015-09, Vol.26 (3), p.185-193

2015

Volltextzugriff (PDF)

A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform

Molecular therapy. Methods & clinical development, 2016-01, Vol.3 (C), p.16031-16031, Article 16031

2016

Volltextzugriff (PDF)

Withdrawal of life sustaining treatment in the ICU - different doctors act differently

Läkartidningen, 2024-06, Vol.121

2024

Volltextzugriff (PDF)

RNA aggregates harness the danger response for potent cancer immunotherapy

Cell, 2024-05, Vol.187 (10), p.2521-2535.e21

2024

Volltextzugriff (PDF)

PDCT-08. TRACKING THE T CELL REPERTOIRE AFTER ADOPTIVE CELL THERAPY IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi202-vi202

2018

Volltextzugriff (PDF)

Enabling redosing of AAV by immune management in Pompe disease: Preclinical to clinical studies

Molecular genetics and metabolism, 2018-02, Vol.123 (2), p.S34-S34

2018

Volltextzugriff (PDF)

A retrospective analysis of the management of unconscious patients from the emergency room (ER) to intensive care (ICU) at Södersjukhuset

Läkartidningen, 2018-09, Vol.115

2018

Volltextzugriff (PDF)

ATIM-34. SINGLE-CELL RNA SEQUENCING REVEALS DYNAMIC IMMUNE RESPONSE CHANGES IN GLIOBLASTOMA PATIENT WITH DURABLE COMPLETE RESPONSE TO CMV PP65-LAMP RNA-PULSED DENDRITIC VACCINES

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi9-vi9

2019

Volltextzugriff (PDF)

Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy

Annals of translational medicine, 2019-07, Vol.7 (13), p.290-290

2019

Volltextzugriff (PDF)

472. Evaluation of Re-Administration of a Recombinant Adeno-Associated Vector Expressing Acid-Alpha-Glucosidase (rAAV9-DES-hGAA) in Pompe Disease: Preclinical to Clinical Planning

Molecular therapy, 2016-05, Vol.24, p.S186-S187

2016

Volltextzugriff (PDF)

IT-35cGMP MANUFACTURING OF EX VIVO EXPANDED TUMOR-SPECIFIC T CELLS AND AMPLIFIED TUMOR RNA-PULSED DC VACCINES TARGETING GLIOBLASTOMA AND MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v117-v117

2014

Volltextzugriff (PDF)

PDCT-15. Re-MATCH: A PHASE 2 MULTI-INSTITUTIONAL CLINICAL TRIAL OF ADOPTIVE CELLULAR THERAPY FOLLOWING MYELOABLATIVE OR NON-MYELOABLATIVE CHEMOTHERAPY IN CHILDREN AND YOUNG ADULTS WITH RECURRENT MEDULLOBLASTOMA AND PNETs

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi149-vi149

2016

Volltextzugriff (PDF)

Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa

Human gene therapy. Clinical development, 2013-03, Vol.24 (1), p.23-28

2013

Volltextzugriff (PDF)

IT-35 cGMP MANUFACTURING OF EX VIVO EXPANDED TUMOR-SPECIFIC T CELLS AND AMPLIFIED TUMOR RNA-PULSED DC VACCINES TARGETING GLIOBLASTOMA AND MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v117-v117

2014

Volltextzugriff (PDF)

Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease

Human gene therapy. Clinical development, 2014-09, Vol.25 (3), p.134-163

2014

Volltextzugriff (PDF)

Swedish patients can receive better anesthesiologic care. Fluid therapy and oxygen administration in major bowel surgery are not optimal according to a questionnaire

Läkartidningen, 2011, Vol.108 (40), p.1963-1967

2011

Volltextzugriff (PDF)

Viscosity of the NaCl + AlCl3 Melt System, Including the Effect of Added Oxide

Journal of chemical and engineering data, 1994-10, Vol.39 (4), p.848-850

1994

Volltextzugriff (PDF)

Viscosity of the NaCl + AlCl sub(3) melt system, including the effect of added oxide

Journal of chemical and engineering data, 1994-01, Vol.39 (4), p.848-850

1994

Volltextzugriff (PDF)

Effect of pressure on the viscosity of liquid ZnCl2

Journal of the Chemical Society. Faraday transactions, 1997, Vol.93 (8), p.1601-1604

1997

Volltextzugriff (PDF)

Luteinizing Hormone Secretion in Anestrous Mares Exposed to Artificially Lengthened Photoperiod and Treated with Estradiol1

Biology of reproduction, 1995-01, Vol.52 (monograph_series1), p.449-457

1995

Volltextzugriff (PDF)

Properties of fused polysulphides—VII. The phase diagram Li 2S/Na 2S/S

Electrochimica acta, 1991, Vol.36 (3), p.673-677

1991

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(59)
Schwedisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(16)
Humans
(15)
Chemistry
(11)
Female
(10)
Physical Sciences
(10)
Chemistry, Physical
(9)
Male
(9)
Medicine, Research & Experimental
(9)
Research & Experimental Medicine
(9)
Animals
(7)
Adult
(5)
Biotechnology & Applied Microbiology
(5)
Chemistry, Multidisciplinary
(5)
Exact Sciences And Technology
(5)
Mice
(5)
Middle Aged
(5)
Aged
(4)
Dependovirus - Genetics
(4)
Glycogen Storage Disease Type Ii - Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes

Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation

Pompe disease gene therapy: Gene Therapy

A simplified purification protocol for recombinant adeno-associated virus vectors

Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning

A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform

Withdrawal of life sustaining treatment in the ICU - different doctors act differently

RNA aggregates harness the danger response for potent cancer immunotherapy

PDCT-08. TRACKING THE T CELL REPERTOIRE AFTER ADOPTIVE CELL THERAPY IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA

Enabling redosing of AAV by immune management in Pompe disease: Preclinical to clinical studies

A retrospective analysis of the management of unconscious patients from the emergency room (ER) to intensive care (ICU) at Södersjukhuset

ATIM-34. SINGLE-CELL RNA SEQUENCING REVEALS DYNAMIC IMMUNE RESPONSE CHANGES IN GLIOBLASTOMA PATIENT WITH DURABLE COMPLETE RESPONSE TO CMV PP65-LAMP RNA-PULSED DENDRITIC VACCINES

Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy

472. Evaluation of Re-Administration of a Recombinant Adeno-Associated Vector Expressing Acid-Alpha-Glucosidase (rAAV9-DES-hGAA) in Pompe Disease: Preclinical to Clinical Planning

IT-35cGMP MANUFACTURING OF EX VIVO EXPANDED TUMOR-SPECIFIC T CELLS AND AMPLIFIED TUMOR RNA-PULSED DC VACCINES TARGETING GLIOBLASTOMA AND MEDULLOBLASTOMA

PDCT-15. Re-MATCH: A PHASE 2 MULTI-INSTITUTIONAL CLINICAL TRIAL OF ADOPTIVE CELLULAR THERAPY FOLLOWING MYELOABLATIVE OR NON-MYELOABLATIVE CHEMOTHERAPY IN CHILDREN AND YOUNG ADULTS WITH RECURRENT MEDULLOBLASTOMA AND PNETs

Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa

IT-35 cGMP MANUFACTURING OF EX VIVO EXPANDED TUMOR-SPECIFIC T CELLS AND AMPLIFIED TUMOR RNA-PULSED DC VACCINES TARGETING GLIOBLASTOMA AND MEDULLOBLASTOMA

Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease

Swedish patients can receive better anesthesiologic care. Fluid therapy and oxygen administration in major bowel surgery are not optimal according to a questionnaire

Viscosity of the NaCl + AlCl3 Melt System, Including the Effect of Added Oxide

Viscosity of the NaCl + AlCl sub(3) melt system, including the effect of added oxide

Effect of pressure on the viscosity of liquid ZnCl2

Luteinizing Hormone Secretion in Anestrous Mares Exposed to Artificially Lengthened Photoperiod and Treated with Estradiol1

Properties of fused polysulphides—VII. The phase diagram Li 2S/Na 2S/S

Suchergebnisse filtern